Undesirable effects and cosmetovigilance after product launch
How to receive, assess, document and report undesirable and serious undesirable effects associated with cosmetic products in the EU.
Read the guide →The PIF must be complete, internally consistent and readily accessible to the Responsible Person. EUCRI organises technical, safety and substantiation documents around the product that is actually placed on the market.
Preparation, review and maintenance of the Product Information File, including the CPSR, GMP information, evidence of effect and change control.
The exact scope is confirmed after reviewing the product, target markets and available documentation.
For ten years following the date on which the last batch of the cosmetic product was placed on the market.
Yes. A PIF audit identifies gaps, inconsistencies and priority corrective actions.
Yes. It must reflect the current product, safety data, labelling and relevant changes.
How to receive, assess, document and report undesirable and serious undesirable effects associated with cosmetic products in the EU.
Read the guide →What Regulation (EU) 2023/1545 changes for fragrance allergen labelling, which thresholds apply and how to prepare formulas and labels for 2026 and 2028.
Read the guide →How to plan reformulation after an ingredient restriction and align testing, CPSR, PIF, labelling, CPNP and packaging stocks.
Read the guide →Send us the essential product details, target markets and available documentation. We will respond by email.